Word: paines
(lookup in dictionary)
(lookup stats)
Dates: during 1980-1989
Sort By: most recent first
(reverse)
...content of pornography inevitably restrict expression, and the repellent and the worthwhile can be so closely braided that no amount of linguistic hairsplitting can untangle them. Drafted with the assistance of MacKinnon and Dworkin, the Indianapolis ordinance targeted materials that showed women in bondage or that treated pain and humiliation as sexual turn-ons. But more sweepingly, it forbade showing women "as sexual objects for domination, conquest, violation, exploitation, possession or use." A federal appeals court was concerned that the ordinance might encompass everything from the ! Iliad to Barbarella, to say nothing of Leda and the Swan...
...play when the pain goes away, and as of yet it hasn't gone away," Fusco said yesterday...
...Lilly has developed a tiny belt of gelatin that binds, like a piece of tape, the top and bottom halves and makes it difficult to open a capsule without tearing it. Sterling Drug uses sound waves to create a kind of spot-weld on capsules of its Panadol pain reliever. Johnson & Johnson says that it too studied new methods of sealing capsules but decided that none was completely secure...
After the Chicago poisonings, which caused Tylenol's share of the pain- killer market to plunge from 35% to 7%, Johnson & Johnson staged what industry experts called a "miracle" comeback. The company spent an estimated $300 million to recall 31 million old packages of Tylenol capsules and promote new ones that were "triple sealed" to resist tampering. Now the company must restore confidence yet again. It will not be easy: the poisoned woman's mother described the plan to withdraw capsules from the market as "three years too late...
...stock price went up 1 1/2 points last week, to 49, in contrast to a fall of 5 3/4 during the week after the poisoning. Investors generally believe that Johnson & Johnson (1985 revenues: $6.4 billion) has the financial wherewithal to preserve Tylenol's position as the best-selling nonprescription pain reliever. During 1985, the brand held a 34% share of the $1.6 billion market. The company's debts are low, and it holds a cash reserve of some $800 million...